$25 million gift from Jim Fitterling gives cancer center a new name and new ambitions
Almost twenty years ago, Jim Fitterling was a rising executive at Dow when he learned he had stage IV appendiceal cancer.
It is a rare disease that often goes unnoticed until it has spread through the abdomen.
He went to Pittsburgh to see Dr. David L. Bartlett, a surgical oncologist known for treating this kind of cancer.
Fitterling went through two major surgeries in which surgeons removed every visible tumor and then washed the abdomen with heated chemotherapy to reach the cancer cells left behind.
He survived.
He went on to run one of the world’s largest materials science companies.
Recently, he came back to thank the people who saved his life in the biggest way he could.
Allegheny Health Network has announced a $25 million personal gift from James R. “Jim” Fitterling, executive chairman and former president and CEO of Dow Inc.
It is the largest philanthropic gift in the health system’s history. In his honor, the AHN Cancer Center and its more than 35 clinical locations will become the AHN James R. Fitterling Cancer Center.
The center treats more than 11,000 patients a year across western Pennsylvania and nearby parts of Ohio, West Virginia, Maryland, and New York.
“When you’re facing a cancer diagnosis, having the right physician, the right treatment, and a reason to hope can make all the difference,” Fitterling said.
“I know that firsthand because of the extraordinary care I received from Dr. Bartlett. My hope is that this gift will help accelerate research and discovery so that more patients have access to innovative treatment options and the best chance of a successful outcome.”
The gift is aimed at the frontier of cancer medicine.
An endowed chair in oncology will help AHN recruit and keep leading physician-scientists. The network’s Biomarker Moonshot, a research effort built on patient data and tissue samples, will grow by another 10,000 patients.
That makes it a larger resource for spotting patterns no single doctor could see.
A thousand patients will take part in multi-omics research supported by artificial intelligence.
This work reads each person’s tumor across several biological layers to understand that cancer and find targets for treatment.
Over five years, the gift will fund five new cell therapy trials with 100 patients.
Over the same period it will fund five new trials for appendiceal and peritoneal cancers, the disease Fitterling knows from the inside.
Two of the most ambitious projects follow a single idea from the lab bench all the way to a patient.
One is a personalized cancer vaccine.
The other is a new T-cell immunotherapy, built through engineering and then tested in human trials.
Both take the body’s own immune system and train it to find and destroy tumors.
Bartlett has long worked toward that goal, hoping one day to offer patients something gentler than the long surgeries that saved Fitterling.
Science is not the whole of it, though.
The gift will also expand AHN’s Community Cancer Patient Ambassador Program and its navigation services.
These help patients and families through the confusing days after a diagnosis, and Fitterling was personally keen to support them.
“Jim understands the stakes and knows that the greatest advances in cancer care happen when we have the ability to turn promising ideas into meaningful treatment options for patients,” Bartlett said.
“His incredible generosity will give our physicians and researchers the resources to pursue bold new approaches, accelerate discoveries, and develop treatments that could change what’s possible for patients and families facing cancer.”
AHN president Mark Sevco called the gift “a powerful investment in the future of cancer care at AHN and in the patients and families who turn to us for hope.”
He spoke at the announcement at Allegheny General Hospital on Pittsburgh’s North Side.
“We’re really, really grateful for how this will grow our program.”
Chief medical officer Dr. Bethany Casagranda said exceptional cancer care means “caring for the whole person.”
She said the gift will help AHN build the teams that make that possible.
The gift deepens a bond that started in an exam room.
Fitterling has already supported the Susan J. and David L. Bartlett, MD Cancer Research Fund, which pays for research into new and more effective treatments.
In past years he has spoken at AHN donor gatherings next to the surgeon who treated him, telling other donors what their support makes possible.
Surviving cancer shaped more than his giving. Fitterling has said openly that facing a stage IV diagnosis gave him a new perspective on life.
It was part of what led him, years later, to come out as gay to Dow’s employees.
He has called that moment liberating, and colleagues met it with overwhelming support. He says the two experiences together changed how he leads.
His philanthropy has always drawn on the same two things: where he came from and what he has lived through.
Fitterling grew up a Missourian. He earned a mechanical engineering degree from the University of Missouri in 1983 and started at Dow two weeks after graduating.
He stayed for more than four decades, became CEO and served from 2018 until this year, and was elected board chair along the way.
In 2019 he gave $6 million to Mizzou’s NextGen Precision Health Institute.
It was one of the first major individual gifts to the university’s flagship research building, which now partly bears his name.
“As a cancer survivor, I’m keenly interested in advancing research that helps patients and their families enjoy better outcomes and better qualities of life,” he said then.
He later gave $10 million to help start Mizzou’s plans for an interdisciplinary energy research center.
That early commitment laid the groundwork for the Payne Energy Innovation Center, which broke ground this fall with a $50 million gift from fellow 1983 engineering graduate David Payne.
Fitterling sits on the center’s advisory board and co-chairs the engineering college’s Dean’s Advisory Council.
He has also co-chaired the AIChE Foundation’s “Doing a World of Good” campaign for the chemical engineering profession. In his adopted hometown of Midland, Michigan, he served as honorary chair of the ABC Cares fundraiser for Make-A-Wish, which grants wishes to children with serious illnesses.
Across all of it, the logic is simple.
Fitterling backs the research that makes an engineer proud, the institutions that formed him, and above all the doctors who gave him back his future.
Now his name will hang over the doors of a cancer center where thousands of patients will arrive each year, as he once did, hoping someone there can help them.